Medherant Limited (“Medherant”), the clinical-stage company developing innovative products for pain and CNS diseases using a unique transdermal delivery technology, TEPI Patch
13th February 2019
Pain affects everyone at some time in their life, be it chronic arthritis or a one-off injury.
21st January 2019
Last year was another busy year for Medherant with a significant milestone reached when we received positive results from the first clinical trials with our TEPI Patch® technology.